Allianz Asset Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.5M Buy
1,074,363
+69,160
+7% +$1.19M 0.02% 700
2026
Q2
$18.1M Buy
1,005,203
+115,599
+13% +$1.62M 0.01% 802
2026
Q1
$8.38M Buy
889,604
+238,957
+37% +$2.62M 0.01% 940
2025
Q4
$8.08M Buy
650,647
+216,909
+50% +$2.88M 0.01% 933
2025
Q3
$6.22M Buy
433,738
+203,834
+89% +$2.79M 0.01% 1020
2025
Q2
$2.82M Buy
229,904
+80,290
+54% +$1.17M ﹤0.01% 1353
2025
Q1
$3.29M Buy
149,614
+71,939
+93% +$1.69M ﹤0.01% 1287
2024
Q4
$1.76M Buy
+77,675
New +$1.7M ﹤0.01% 1487
2023
Q4
– Sell
-7,008
Closed -$268K – 2184
2023
Q3
$268K Buy
+7,008
New +$295K ﹤0.01% 2086
2019
Q4
– Sell
-3,524
Closed -$212K – 2807
2019
Q3
$212K Buy
+3,524
New +$210K ﹤0.01% 2616
2019
Q2
– Sell
-4,550
Closed -$254K – 2719
2019
Q1
$254K Buy
+4,550
New +$232K ﹤0.01% 2521
2018
Q1
– Sell
-23,999
Closed -$1.15M – 2668
2017
Q4
$1.15M Sell
23,999
-180,493
-88% -$8.83M ﹤0.01% 2196
2017
Q3
$10.3M Sell
204,492
-90,589
-31% -$4.65M 0.01% 1309
2017
Q2
$16.1M Buy
295,081
+231,059
+361% +$11M 0.02% 1081
2017
Q1
$2.7M Sell
64,022
-91,918
-59% -$3.93M ﹤0.01% 1884
2016
Q4
$6.69M Buy
155,940
+99,090
+174% +$4.03M 0.01% 1533
2016
Q3
$2.35M Buy
+56,850
New +$2.38M ﹤0.01% 1935

Other funds holding IART

Allianz Asset Management's IART Position: Q3 2026 in Review

Allianz Asset Management increased its Integra LifeSciences (IART) stake by 6.9% in Q3 2026, buying an estimated $1.19M and bringing the position to 1,074,363 shares worth $17.5M. The position accounts for 0.02% of the portfolio, ranked #700.

Allianz Asset Management first reported a position in IART in Q3 2016 and has held it in 17 quarters since. The position peaked at $18.1M in Q2 2026. 233 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • Allianz Asset Management held 1,074,363 shares of Integra LifeSciences worth $17.5M as of Q3 2026.
  • Allianz Asset Management bought 69,160 Integra LifeSciences shares in Q3 2026, an estimated $1.19M.
  • Integra LifeSciences made up 0.02% of Allianz Asset Management's portfolio in Q3 2026, its #700 holding.
  • Allianz Asset Management first reported a position in Integra LifeSciences in Q3 2016 and has held it in 17 quarters since.
  • Allianz Asset Management's Integra LifeSciences position peaked at $18.1M in Q2 2026.
  • 233 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Allianz Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.